Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Selling General And Administration | 1.7M | 188,000 | 181,000 | 347,000 | 136,000 | -- |
| General And Administrative Expense | 1.7M | 188,000 | 181,000 | 347,000 | 136,000 | -- |
| Other Operating Expenses | 257,000 | 145,000 | 136,000 | 135,000 | 130,000 | -- |
| Operating Expense | 2.0M | 333,000 | 317,000 | 482,000 | 266,000 | -- |
| Operating Income | -2.0M | -333,000 | -317,000 | -482,000 | -266,000 | -- |
| EBIT | -2.0M | -333,000 | -317,000 | -482,000 | -266,000 | -- |
| Other Income Expense | 104,000 | -4,000 | -261,000 | -329,000 | -- | 6,000 |
| Other Non Operating Income Expenses | 51,000 | -- | -- | 0.00 | -- | 6,000 |
| Gain On Sale Of Security | 53,000 | -4,000 | -261,000 | -329,000 | -- | -- |
| Pretax Income | -1.9M | -337,000 | -578,000 | -811,000 | -266,000 | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -1.9M | -337,000 | -578,000 | -811,000 | -266,000 | -- |
| Net Income From Continuing Operation Net Minority Interest | -1.9M | -337,000 | -578,000 | -811,000 | -266,000 | -- |
| Net Income Including Noncontrolling Interests | -1.9M | -337,000 | -578,000 | -811,000 | -266,000 | -- |
| Net Income Common Stockholders | -1.9M | -337,000 | -578,000 | -811,000 | -266,000 | -- |
| Net Income | -1.9M | -337,000 | -578,000 | -811,000 | -266,000 | -- |
| EBITDA | -2.0M | -333,000 | -317,000 | -482,000 | -266,000 | -- |
| Normalized EBITDA | -2.0M | -329,000 | -56,000 | -153,000 | -266,000 | -- |
| Basic EPS | -0.06 | 0.00 | 0.00 | -- | -0.01 | 0.00 |
| Diluted EPS | -0.06 | 0.00 | 0.00 | -- | -0.01 | 0.00 |
| Basic Average Shares | 32.9M | 29.2M | 28.6M | -- | 24.7M | 24.7M |
| Diluted Average Shares | 32.9M | 29.2M | 28.6M | -- | 24.7M | 24.7M |
| Total Unusual Items | 53,000 | -4,000 | -261,000 | -329,000 | -- | -- |
| Total Unusual Items Excluding Goodwill | 53,000 | -4,000 | -261,000 | -329,000 | -- | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | -1.9M | -333,000 | -317,000 | -482,000 | -266,000 | -- |
| Diluted NI Availto Com Stockholders | -1.9M | -337,000 | -578,000 | -811,000 | -266,000 | -- |
| Insurance And Claims | 43,000 | 5,000 | 5,000 | 6,000 | 51,000 | -- |
| Net Income Continuous Operations | -1.9M | -337,000 | -578,000 | -811,000 | -266,000 | -- |
| Other Gand A | 213,000 | 134,000 | 127,000 | 292,000 | 36,000 | -- |
| Salaries And Wages | 1.5M | 49,000 | 49,000 | 49,000 | 49,000 | -- |
| Total Expenses | 2.0M | 333,000 | 317,000 | 482,000 | 266,000 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 4.3M | 955,000 | 1.6M | 2.1M | 680,000 | -- |
| Cash Cash Equivalents And Short Term Investments | 4.5M | 1.1M | 1.8M | 2.5M | 680,000 | -- |
| Cash Financial | -- | -- | -- | -- | 680,000 | 942,000 |
| Other Short Term Investments | 189,000 | 161,000 | 161,000 | 321,000 | -- | -- |
| Accounts Receivable | 138,000 | 87,000 | 104,000 | 131,000 | 27,000 | -- |
| Receivables | 138,000 | 87,000 | 104,000 | 131,000 | 27,000 | -- |
| Prepaid Assets | 266,000 | 176,000 | 181,000 | 137,000 | 154,000 | -- |
| Current Assets | 4.9M | 1.4M | 2.1M | 2.7M | 861,000 | -- |
| Gross PPE | 17.4M | 16.5M | 16.5M | 16.2M | 18.4M | -- |
| Accumulated Depreciation | -1.4M | -1.4M | -1.4M | -1.4M | -1.3M | -- |
| Net PPE | 15.9M | 15.1M | 15.1M | 14.9M | 17.1M | -- |
| Total Non Current Assets | 16.3M | 15.4M | 15.4M | 15.2M | 17.2M | -- |
| Total Assets | 21.2M | 16.8M | 17.5M | 18.0M | 18.0M | -- |
| Accounts Payable | 714,000 | 334,000 | 583,000 | 604,000 | 275,000 | -- |
| Payables | 714,000 | 334,000 | 583,000 | 604,000 | 275,000 | -- |
| Payables And Accrued Expenses | 733,000 | 334,000 | 617,000 | 672,000 | 320,000 | -- |
| Current Accrued Expenses | 19,000 | 0.00 | 34,000 | 68,000 | 45,000 | -- |
| Current Deferred Revenue | -- | -- | -- | -- | 207,000 | -- |
| Current Liabilities | 733,000 | 334,000 | 617,000 | 672,000 | 527,000 | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 733,000 | 334,000 | 617,000 | 672,000 | 527,000 | -- |
| Common Stock | 197.3M | 193.3M | 193.3M | 192.9M | 191.4M | -- |
| Capital Stock | 197.3M | 193.3M | 193.3M | 192.9M | 191.4M | -- |
| Retained Earnings | -193.2M | -191.3M | -191.0M | -190.4M | -189.6M | -- |
| Gains Losses Not Affecting Retained Earnings | -379,000 | -790,000 | -624,000 | -732,000 | -69,000 | -- |
| Common Stock Equity | 20.5M | 16.5M | 16.9M | 17.3M | 17.5M | -- |
| Stockholders Equity | 20.5M | 16.5M | 16.9M | 17.3M | 17.5M | -- |
| Total Equity Gross Minority Interest | 20.5M | 16.5M | 16.9M | 17.3M | 17.5M | -- |
| Total Capitalization | 20.5M | 16.5M | 16.9M | 17.3M | 17.5M | -- |
| Net Tangible Assets | 20.5M | 16.5M | 16.9M | 17.3M | 17.5M | -- |
| Tangible Book Value | 20.5M | 16.5M | 16.9M | 17.3M | 17.5M | -- |
| Working Capital | 4.2M | 1.0M | 1.5M | 2.1M | 334,000 | -- |
| Invested Capital | 20.5M | 16.5M | 16.9M | 17.3M | 17.5M | -- |
| Share Issued | 42.6M | 29.2M | 29.2M | 29.2M | 24.7M | -- |
| Ordinary Shares Number | 42.6M | 29.2M | 29.2M | 29.2M | 24.7M | -- |
| Current Deferred Liabilities | -- | -- | -- | -- | 207,000 | -- |
| Financial Assets | 110,000 | 136,000 | 140,000 | 247,000 | -- | -- |
| Foreign Currency Translation Adjustments | -379,000 | -790,000 | -624,000 | -732,000 | -69,000 | -- |
| Machinery Furniture Equipment | 25,000 | 25,000 | 31,000 | 25,000 | 25,000 | -- |
| Non Current Prepaid Assets | 263,000 | 212,000 | 180,000 | 125,000 | 125,000 | -- |
| Other Equity Interest | 16.8M | 15.3M | 15.2M | 15.5M | 15.8M | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -108,000 | -508,000 | -292,000 | -174,000 | -212,000 | -- |
| Cash Flow From Continuing Operating Activities | -108,000 | -508,000 | -292,000 | -174,000 | -212,000 | -- |
| Stock Based Compensation | 1.4M | -- | -- | 0.00 | 0.00 | 794,000 |
| Change In Working Capital | 258,000 | -261,000 | -72,000 | 265,000 | 54,000 | -- |
| Change In Receivables | -51,000 | 17,000 | 27,000 | -104,000 | -11,000 | -- |
| Change In Payables And Accrued Expense | 399,000 | -283,000 | -55,000 | 352,000 | 92,000 | -- |
| Other Non Cash Items | 87,000 | 88,000 | 87,000 | 88,000 | 0.00 | -- |
| Capital Expenditure | -- | -817,000 | -1.0M | -2,000 | -- | -146,000 |
| Purchase Of PPE | -53,000 | 1,000 | -62,000 | -2,000 | -38,000 | -- |
| Net PPE Purchase And Sale | -1.6M | 658,000 | 786,000 | 2.7M | 54,000 | -- |
| Investing Cash Flow | -563,000 | -188,000 | -245,000 | 661,000 | 27,000 | -- |
| Cash Flow From Continuing Investing Activities | -563,000 | -188,000 | -245,000 | 661,000 | 27,000 | -- |
| Issuance Of Capital Stock | -- | -- | -- | 1.2M | 0.00 | 0.00 |
| Net Common Stock Issuance | -- | -- | -- | 1.2M | 0.00 | 0.00 |
| Financing Cash Flow | -- | -- | -- | 1.2M | 0.00 | 0.00 |
| Cash Flow From Continuing Financing Activities | -- | -- | -- | 1.2M | 0.00 | 0.00 |
| Effect Of Exchange Rate Changes | 78,000 | 1,000 | 43,000 | -181,000 | -77,000 | -- |
| Changes In Cash | 3.3M | -696,000 | -537,000 | 1.6M | -185,000 | -- |
| Beginning Cash Position | 955,000 | 1.6M | 2.1M | 680,000 | 942,000 | -- |
| End Cash Position | 4.3M | 955,000 | 1.6M | 2.1M | 680,000 | -- |
| Free Cash Flow | 1.6M | -1.3M | -1.3M | -176,000 | 88,000 | -- |
| Capital Expenditure Reported | -- | -818,000 | -972,000 | -- | -- | -146,000 |
| Change In Prepaid Assets | -90,000 | 5,000 | -44,000 | 17,000 | -27,000 | -- |
| Common Stock Issuance | -- | -- | -- | 1.2M | 0.00 | 0.00 |
| Net Income From Continuing Operations | -1.9M | -337,000 | -578,000 | -811,000 | -266,000 | -- |
| Net Other Investing Changes | -795,000 | -28,000 | -59,000 | -2.1M | -365,000 | -- |
| Sale Of PPE | -1.5M | 657,000 | 848,000 | 2.8M | 92,000 | -- |
| Unrealized Gain Loss On Investment Securities | 5,000 | 2,000 | 271,000 | -- | 0.00 | 0.00 |